Michael Morrissey
CIK: 0001202096
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (41 total)
- May 21, 2026VERA
Vera Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
17.1K shares- - May 18, 2026EXEL
EXELIXIS, INC.
Gift(G)Direct124K shares- - May 18, 2026EXEL
EXELIXIS, INC.
Gift(G)Indirect124K shares- - May 15, 2026EXEL
EXELIXIS, INC.
Tax Payment(F)Direct128.5K shares at avg. $51.10$6.6M - May 6, 2026EXEL
EXELIXIS, INC.
Gift(G)Indirect109.7K shares- - Feb 26, 2026EXEL
EXELIXIS, INC.
Award(A)Direct160.4K shares- - Feb 24, 2026EXEL
EXELIXIS, INC.
Gift(G)Indirect100.3K shares- - Feb 18, 2026EXEL
EXELIXIS, INC.
Gift(G)Direct125.1K shares- - Feb 18, 2026EXEL
EXELIXIS, INC.
Gift(G)Indirect125.1K shares- - Feb 17, 2026EXEL
EXELIXIS, INC.
Gift(G)Direct250.7K shares- - Feb 17, 2026EXEL
EXELIXIS, INC.
Gift(G)Indirect250.7K shares- - Feb 15, 2026EXEL
EXELIXIS, INC.
Tax Payment(F)Direct120.4K shares at avg. $43.92$5.3M - Feb 13, 2026EXEL
EXELIXIS, INC.
Tax Payment(F)Direct369.6K shares at avg. $43.92$16.2M - Feb 13, 2026EXEL
EXELIXIS, INC.
Exercise(M)Direct494.7K shares at avg. $21.31$10.5M - Jan 15, 2026EXEL
EXELIXIS, INC.
Tax Payment(F)Direct139.5K shares at avg. $45.23$6.3M - Jan 15, 2026EXEL
EXELIXIS, INC.
Award(A)Direct548.1K shares- - Nov 12, 2025EXEL
EXELIXIS, INC.
Gift(G)Indirect101.5K shares- - Nov 12, 2025EXEL
EXELIXIS, INC.
Gift(G)Direct101.5K shares- - Nov 12, 2025EXEL
EXELIXIS, INC.
Gift(G)Indirect80K shares- - Nov 11, 2025EXEL
EXELIXIS, INC.
Gift(G)Indirect160K shares- - May 16, 2025EXEL
EXELIXIS, INC.
Gift(G)Indirect87.9K shares- - May 16, 2025EXEL
EXELIXIS, INC.
Gift(G)Direct87.9K shares- - May 15, 2025EXEL
EXELIXIS, INC.
Tax Payment(F)Direct104.8K shares at avg. $44.65$4.7M - May 14, 2025EXEL
EXELIXIS, INC.
Tax Payment(F)Direct220.5K shares at avg. $44.65$9.8M - May 14, 2025EXEL
EXELIXIS, INC.
Exercise(M)Direct308.4K shares at avg. $18.80$5.8M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 21, 2026 |  VERA Vera Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 17,084 | - | - | Direct |
| May 18, 2026 |  EXEL EXELIXIS, INC. | Gift(G) | 124,047 | - | $0 | Direct |
| May 18, 2026 | EXEL EXELIXIS, INC. | Gift(G) | 124,047 | - | $0 | Indirect |
| May 15, 2026 | EXEL EXELIXIS, INC. | Tax Payment(F) | 128,497 | $51.10 | $6,566,197 | Direct |
| May 6, 2026 | EXEL EXELIXIS, INC. | Gift(G) | 109,676 | - | $0 | Indirect |
| Feb 26, 2026 | EXEL EXELIXIS, INC. | Award(A) | 160,437 | - | $0 | Direct |
| Feb 24, 2026 | EXEL EXELIXIS, INC. | Gift(G) | 100,278 | - | $0 | Indirect |
| Feb 18, 2026 | EXEL EXELIXIS, INC. | Gift(G) | 125,094 | - | $0 | Direct |
| Feb 18, 2026 | EXEL EXELIXIS, INC. | Gift(G) | 125,094 | - | $0 | Indirect |
| Feb 17, 2026 | EXEL EXELIXIS, INC. | Gift(G) | 250,736 | - | $0 | Direct |
| Feb 17, 2026 | EXEL EXELIXIS, INC. | Gift(G) | 250,736 | - | $0 | Indirect |
| Feb 15, 2026 | EXEL EXELIXIS, INC. | Tax Payment(F) | 120,390 | $43.92 | $5,287,529 | Direct |
| Feb 13, 2026 | EXEL EXELIXIS, INC. | Tax Payment(F) | 369,606 | $43.92 | $16,233,096 | Direct |
| Feb 13, 2026 | EXEL EXELIXIS, INC. | Exercise(M) | 494,700 | $21.31 | $10,542,057 | Direct |
| Jan 15, 2026 | EXEL EXELIXIS, INC. | Tax Payment(F) | 139,524 | $45.23 | $6,310,671 | Direct |
| Jan 15, 2026 | EXEL EXELIXIS, INC. | Award(A) | 548,073 | - | $0 | Direct |
| Nov 12, 2025 | EXEL EXELIXIS, INC. | Gift(G) | 101,548 | - | - | Indirect |
| Nov 12, 2025 | EXEL EXELIXIS, INC. | Gift(G) | 101,548 | - | - | Direct |
| Nov 12, 2025 | EXEL EXELIXIS, INC. | Gift(G) | 80,000 | - | - | Indirect |
| Nov 11, 2025 | EXEL EXELIXIS, INC. | Gift(G) | 160,000 | - | - | Indirect |
| May 16, 2025 | EXEL EXELIXIS, INC. | Gift(G) | 87,871 | - | - | Indirect |
| May 16, 2025 | EXEL EXELIXIS, INC. | Gift(G) | 87,871 | - | - | Direct |
| May 15, 2025 | EXEL EXELIXIS, INC. | Tax Payment(F) | 104,769 | $44.65 | $4,677,936 | Direct |
| May 14, 2025 | EXEL EXELIXIS, INC. | Tax Payment(F) | 220,494 | $44.65 | $9,845,057 | Direct |
| May 14, 2025 | EXEL EXELIXIS, INC. | Exercise(M) | 308,365 | $18.80 | $5,797,262 | Direct |
1-25 of 41 transactions
About MORRISSEY MICHAEL
MORRISSEY MICHAEL (SEC CIK 0001202096) files insider reports with the SEC as Director of Vera Therapeutics, Inc. (VERA) and President and CEO of EXELIXIS, INC. (EXEL).
Signal8 holds 18 ownership filings by MORRISSEY MICHAEL, all Form 4s, filed between Oct 3, 2024 and May 26, 2026. Those filings report 41 transactions, from Oct 1, 2024 to May 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on MORRISSEY MICHAEL's filings is in ALAMEDA, CA.
Recent filings by MORRISSEY MICHAEL
- May 21, 2026: Grant or award of VERA derivative securities (Form 4, code A).
- May 18, 2026: Gifts of EXEL shares (2 lines, Form 4, code G).
- May 15, 2026: Tax withholding of EXEL shares (Form 4, code F).
- May 6, 2026: Gift of EXEL shares (Form 4, code G).
- Feb 26, 2026: Grant or award of EXEL shares (Form 4, code A).
Other insiders filing for Vera Therapeutics, Inc. (VERA)
- Fordyce Marshall, PRESIDENT AND CEO
- Young Joseph R, SVP, FINANCE, CHIEF ACCT OFFCR
- Boman Nancy Lee, Chief Regulatory Officer
- Morrison Scott W, Director
- Cheng Andrew, Director
- SEIDENBERG BETH C, Director